Estimating effect of antiviral drug use during pandemic (H1N1) 2009 outbreak, United States (Q30406680)

11 August 2017

Estimating effect of antiviral drug use during pandemic (H1N1) 2009 outbreak, United States (English)

1 reference

11 August 2017

0 references

United States of America

0 references

4

Matthew Biggerstaff

1 reference

11 August 2017

10

Martin I Meltzer

1 reference

11 August 2017

2

Anita Patel

1 reference

11 August 2017

8

Rebekah H Borse

1 reference

11 August 2017

Charisma Y Atkins

1

1 reference

11 August 2017

Thomas H Taylor

3

1 reference

11 August 2017

Toby L Merlin

5

1 reference

11 August 2017

Stephanie M Dulin

6

1 reference

11 August 2017

Benjamin A Erickson

7

1 reference

11 August 2017

Robert Hunkler

9

1 reference

11 August 2017

1 September 2011

1 reference

Emerging Infectious Diseases

11 August 2017

1 reference

11 August 2017

17

1 reference

11 August 2017

9

1 reference

11 August 2017

1591-1598

1 reference

Estimating the burden of 2009 pandemic influenza A (H1N1) in the United States (April 2009-April 2010).

11 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3358088

Effects of adverse events on the projected population benefits and cost-effectiveness of using live attenuated influenza vaccine in children aged 6 months to 4 years

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3358088

Adverse drug effects following oseltamivir mass treatment and prophylaxis in a school outbreak of 2009 pandemic influenza A(H1N1) in June 2009, Sheffield, United Kingdom.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3358088

Estimates of the prevalence of pandemic (H1N1) 2009, United States, April-July 2009.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3358088

Economic value of seasonal and pandemic influenza vaccination during pregnancy.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3358088

Oseltamivir and the risk of influenza-related complications and hospitalizations in patients with diabetes

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3358088

Impact of oseltamivir treatment on influenza-related lower respiratory tract complications and hospitalizations.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3358088

Early administration of oral oseltamivir increases the benefits of influenza treatment

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3358088

Oral oseltamivir treatment of influenza in children.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3358088

Zanamivir for the treatment of influenza A and B infection in high-risk patients: a pooled analysis of randomized controlled trials

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3358088

Effect of zanamivir on duration and resolution of influenza symptoms

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3358088

Clinical efficacy and safety of the orally inhaled neuraminidase inhibitor zanamivir in the treatment of influenza: a randomized, double-blind, placebo-controlled European study

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3358088

Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza: a randomized controlled trial. US Oral Neuraminidase Study Group

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3358088

Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenzavirus infections. GG167 Influenza Study Group.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3358088

Recovery of drug-resistant influenza A virus during therapeutic use of rimantadine

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3358088

High costs of influenza: Direct medical costs of influenza disease in young children

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3358088

Oseltamivir adherence and side effects among children in three London schools affected by influenza A(H1N1)v, May 2009 - an internet-based cross-sectional survey.

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3358088

Study of the impact of oseltamivir on the risk for pneumonia and other outcomes of influenza, 2000-2005.

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3358088

Impact of oseltamivir on the incidence of secondary complications of influenza in adolescent and adult patients: results from a retrospective population-based study

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3358088

Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial. Neuraminidase Inhibitor Flu Treatment Investigator Group.

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3358088

Cost of treating influenza in emergency department and hospital settings

26 November 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21888783

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Randomised trial of efficacy and safety of inhaled zanamivir in treatment of influenza A and B virus infections. The MIST (Management of Influenza in the Southern Hemisphere Trialists) Study Group

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21888783

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Oseltamivir and influenza-related complications, hospitalization and healthcare expenditure in healthy adults and children

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21888783

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.3201/EID1709.110295

1 reference

11 August 2017

1 reference

11 August 2017

1 reference